Transcenta Holding Limited (6628.HK)
HKD 1.25
(2.46%)
HKD 1.25
(2.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.69 Billion CNY | -20.67% |
| 2022 | 2.13 Billion CNY | -16.13% |
| 2021 | 2.54 Billion CNY | 21.71% |
| 2020 | 2.09 Billion CNY | 33.54% |
| 2019 | 1.56 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.47 Billion CNY | -13.0% |
| 2024 Q2 | 1.47 Billion CNY | 0.0% |
| 2023 Q4 | 1.69 Billion CNY | 0.0% |
| 2023 Q1 | 1.93 Billion CNY | -9.58% |
| 2023 Q3 | 1.69 Billion CNY | -12.27% |
| 2023 Q2 | 1.93 Billion CNY | 0.0% |
| 2023 FY | 1.69 Billion CNY | -20.67% |
| 2022 FY | 2.13 Billion CNY | -16.13% |
| 2022 Q4 | 2.13 Billion CNY | 0.0% |
| 2022 Q3 | 2.13 Billion CNY | -12.06% |
| 2022 Q2 | 2.42 Billion CNY | 0.0% |
| 2022 Q1 | 2.42 Billion CNY | -4.63% |
| 2021 FY | 2.54 Billion CNY | 21.71% |
| 2021 Q4 | 2.54 Billion CNY | 0.0% |
| 2021 Q3 | 2.54 Billion CNY | 13.5% |
| 2021 Q2 | 2.24 Billion CNY | -4.42% |
| 2021 Q1 | 2.34 Billion CNY | 12.19% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 2.09 Billion CNY | 33.54% |
| 2020 Q4 | 2.09 Billion CNY | 0.0% |
| 2020 Q3 | 2.09 Billion CNY | 0.0% |
| 2019 FY | 1.56 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -313.008% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 84.945% |